Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Open accessThe DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Abstract
Mood disorders are common, chronic, recurrent mental illnesses that affect the lives of millions of individuals worldwide. To date, the monoaminergic systems (serotonergic, noradrenergic and dopaminergic) in the brain have received the greatest attention in neurobiological studies of mood disorders, and most therapeutics target these systems. However, there is growing evidence that the glutamatergic system is central to the neurobiology and treatment of these disorders. Here, we review data supporting the involvement of the glutamatergic system in mood-disorder pathophysiology as well as the efficacy of glutamatergic agents in mood disorders. We also discuss exciting new prospects for the development of improved therapeutics for these devastating disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This could lead to astrocyte/microglia imbalance, glutamatergic overproduction and excitotoxic neuronal damage (Sanacora et al., 2008) with impact on synapse functionality.”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Sanacora et al., 2008
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, increased glutamate levels has been associated with mechanisms involved in stress and depression, such as neuro-inflammatory process, decreased levels of neurotrophic factors, diminished neurogenesis, and neuroplasticity impairment [116,117].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [117]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, rapidly acting antidepressants were discovered in the glutamatergic system (Berman et al., 2000;Sanacora et al., 2008).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Sanacora et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“Several classes of antidepressants as well as SSRIs are known to exert action on the glutamate system by influencing NMDA or AMPA receptor transcription (Sanacora et al., 2008).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Sanacora et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“Glia also play an important role in regulating the synthesis and reuptake of glutamate and thereby influence synaptic function and morphology16,17.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Although most patients with mood disorders receive some benefit from available treatment”
BackgroundTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Self-citationA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Self-citationEvidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043 · cited 1×
“, and is approved for the treatment of moderate to severe Alzheimer's disease, in which it has been shown to enhance cognition and minimize clinical deterioration in patients with Alzheimer's disease, vascular dementia or mixed dementi”
BackgroundMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Research works printed but not linked: 1
- Preskorn, S. et al. A placebo-controlled trial of the NR2B subunit specific NMDA antagonist CP-101,606 plus paroxetine for treatment resistant depression (TRD). Annual Conference of the American Psychological Association (San Francisco, California) 154 (2007).
Cited by
Items 801–900 of 1,000
Cattani, D. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Activity-dependent gene regulation in neurons: energy coupling and a novel biosensor
Li, Z. (2015) · OpenBU (Boston University) · Cited by 1
Genetic analysis of bipolar disorder and alcohol use disorder
Dalvie, S. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 1
Touchscreen Assessment of Motivation and Reinforcement-Related Choice Behaviour in Mice
Phillips, B. U. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.24393 · Cited by 1
Sales, A. J. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-27112018-153336 · Cited by 1
Zhu, X., Nedelcovych, M. T., Thomas, A. G., Hasegawa, Y., Moreno-Megui, A., Coomer, W., Vohra, V., Saito, A., Perez, G., Wu, Y., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0354-3 · Cited by 1
Saayman, J. L. B. (2019) · Boloka Institutional Repository (North-west University) · Cited by 1
Dornbierer, D. (2019) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-b-000348232 · Cited by 1
Michelon, L. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-25102019-131555 · Cited by 1
Brain networks in pharmacological fMRI of NMDA antagonists
Becker, R. (2019) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00027272 · Cited by 1
Voineskos, D. (2019) · TSpace (University of Toronto) · Cited by 1
Conception et synthèse de nouveaux agonistes de récepteurs métabotropiques du glutamate
Commare, B. (2014) · theses.fr (ABES) · doi:10.70675/901b7526z0320z4c35zb739z5fb67b9319a6 · Cited by 1
Therapeutic doses of ketamine acutely attenuate the aversive effect of losses during decision-makingPreprint
Oemisch, M., & Seo, H. (2023) · eLife · doi:10.7554/elife.87529.1 · Cited by 1
Fu, Y., Gao, Y., Zou, J., Zhao, W., Yang, H., Li, X., Sun, Y., Jiang, Z., Lin, Y., Ye, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4739679/v1 · Cited by 1
Qian, R., Gao, H., Qiu, B., Li, Z., Gu, B., Ye, T., Wu, D., & Zhao, Z. (2024) · medRxiv · doi:10.1101/2024.11.20.24317665 · Cited by 1
Kiselycznyk, C., & Sanacora, G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1056-4_17
Self-citationChronische und therapieresistente Depressionen (ICD-10 F3)
Schramm, E., & Bauer, M. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50012-5
Shaw, A. D. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Akbarian, S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777271.036
Ketamine: An Old Anesthetic, A New Antidepressant
Karacaer, F. (2014) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20140430125304
Efectividad de la ketamina en depresión bipolar: revisión sistemática de la literatura
Guerrero, J. E. R., & Ceicedo, A. P. S. (2013) · Repositorio Institucional E-DocUR (Universidad Del Rosario) · doi:10.48713/10336_4840
Gigante, A. D. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2013.tde-18122013-150223
Bipolar disorder and cognitive functioning : a two-year naturalistic study
Arts, B. M. G. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120511ba
Millàs, M. S. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Sorrento, C. M., Rayport, S., Mihali, A., Subramani, S., Macdonald, J., Katz, F., & Katz, F. (2022) · Columbia Undergraduate Science Journal · doi:10.52214/cusj.v6i.6369
Flight, M. H. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2949
Excitatory amino acid transporter expression and regulation in prefrontal cortex in schizophrenia
Bauer, D. (2010) · Deep Blue (University of Michigan)
Flight, M. H. (2009) · Nature reviews. Neuroscience · doi:10.1038/nrn2690
de Souza, M. B. R., & de Oliveira, J. R. M. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9771-z
NMDA Antagonism in the treatment of Major Depressive Disorder
Chalikiopoulos, A. P. A. (2013) · Utrecht University Repository (Utrecht University)
Rapid Antidepressant Action of Ketamine in Psychiatric Patients with Suicidality - a Case Series
Raj, R., & Kumar, R. (2014) · American Journal of Medical Sciences and Medicine · doi:10.12691/ajmsm-2-2-4
Monoaminergic Regulation of MeCP2 Phosphorylation in Mouse Models of Psychiatric Disease
Hutchinson, A. N. (2011) · DukeSpace (Duke University)
TITLE PAGE Genetic alterations in the aetiology of depression
Kristensen, A. F., & Lichota, J. (2013)
Thesis, D., & Würzburg, J.-M.-U. (2012)
Experimental Pharmacologic Approaches for the Reduction of Suicidal Ideation and Behavior
Ballard, E. D., Richards, E. M., Ionescu, D. F., Niciu, M. J., Voort, J. V., & Zarate, C. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-09964-4_12
Self-citationTHE ROLE OF GLIAL GLUTAMATE TRANSPORTER GLT-1 OVER-EXPRESSION IN MITIGATING VISCERAL NOCICEPTION
Lin, Y. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Oliveira‐Giacomelli, Á. (2014)
Zenki, K. C. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
[An integrated program for psychosis].
Tassara, J. M., Diaz, J., & Mourgues, C. (1980) · PubMed
Specific modalities of treatment
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.024
Glutamat als pathobiologischer Faktor bei endogenen Psychosen
Ehrlich, A. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10128
Integrated Biobehavioral Analysis of Sex Differences in a Rat Model of Schizophrenia
Feinstein, I. (2011) · SUNY Digital Repository Support (State University of New York System)
New approaches to discover antidepressants targeting stress-related pathways
Iijima, M., Shimazaki, T., Yoshimizu, T., Karasawa, J.-I., & Chaki, S. (2010) · Folia Pharmacologica Japonica · doi:10.1254/fpj.136.137
Depression: Alternative bei Therapieresistenz
Piber, D., Regen, F., & van Hall, F. (2013) · NeuroTransmitter · doi:10.1007/s15016-013-0236-6
Park, J. W., Kim, W., Shin, K.-M., & Noh, J. S. (2014) · 대한정신약물학회지
Discovery and Clinical Data for a Novel AMPA Receptor Positive Modulator
Ward, S. E. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00099
Niubó, M. (2014) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Sato, V. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2011.tde-22062011-090727
Finn, R. (2012) · UR Research (University of Rochester)
Kruger, R. (2014) · Boloka Institutional Repository (North-west University)
Efeitos da N-acetilisteína em modelo de estresse sub-crônico por contenção em camundongos BALB/c
Giongo, F. (2016) · Lume (Universidade Federal do Rio Grande do Sul)
Insulin receptor sensitization improves affective pathology in various mouse models
Nunes, J. P. D. C. A. V. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151221jc
Chronische und therapieresistente Depressionen (ICD-10 F3)
Schramm, E., Bauer, M., & Adli, M. (2013) · Elsevier eBooks · doi:10.1016/b978-3-437-24904-4.00011-2
Shim, S. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6173
SLEEP-LIKE CORTICAL BISTABILITY IN VEGETATIVE STATE PATIENTS
Fecchio, M. (2015) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/m-fecchio_phd2015-12-02
Jasaui, Y. (2016) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25831
Mapping the Molecular Determinants of Positive Allosteric Modulators of the mGlu2 Receptor
Russo, B. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Primini, E. O. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.59.2017.tde-12042017-140133
Conditions for the emergence of corticostriatal synaptic plasticity
Valtcheva, S. (2016) · theses.fr (ABES) · doi:10.70675/f70ff8c5z00c9z4400za0f8z8b334428eade
Azevedo, J. A. (2016) · Deep Blue (University of Michigan)
Sato, V. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2017.tde-20072016-091556
Mecanismos envolvidos na ação antidepressiva de tabebuia avellanedae
Freitas, A. E. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metabotropic Glutamate Receptor 2 Activation: Computational Predictions and Experimental Validation
Ellaithy, A. (2018) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/d3hq-ee02
David, J. (2018) · Trinity's Access to Research Output (TARA) (Trinity College Dublin)
The role of HDAC5, SIRT2 and VGLUT1 in antidepressant action
Muñoz-Cobo, I. (2017) · Depósito Académico Digital Universidad de Navarra (University of Navarra)
Targeting Glutamate in Prostate Cancer-Induced Depression
Young, K. (2017) · MacSphere (McMaster University) · doi:10.71548/24670
Isolation-rearing from weaning to investigate depressive-like behaviour in the rat
Dunphy-Doherty, F. (2018) · Nottingham ePrints (University of Nottingham)
N‐Methyl‐D‐Aspartate (NMDA) Receptor Antagonists
Ogata, N., & Dantas, L. M. D. S. (2019) · Wiley eBooks · doi:10.1002/9781119226253.ch12
Glutamate as a Neural Stress Factor in Humans and Animals
Kania, B. F., Ferdyn, K., Wojnar, T., & Lonc, G. (2019) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2019.92002
Physiology of sleep-wake regulation in health and disease: A molecular imaging and a clinical study
Hefti, K. (2012) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-75685
Charles Bovary. Landarzt: Gedanken zu Jean Amérys letztem Roman — Teil 2
Köpf, G. (2013) · NeuroTransmitter · doi:10.1007/s15016-013-0251-7
Effects of Pregabalin and Environmental Familiarity upon Hippocampal Theta
Hines, M. (2019) · Durham e-Theses (Durham University)
Aleksandrova, L. R. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0383291
Guimarães, M. R. C. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-06092019-145707
The effects of perinatal Fluoxetine treatment on offspring behaviour and neurobiology
Millard, S. J. (2019) · Research Online (University of Wollongong)
Belokoskova, S. G., & Tsikunov, S. G. (2016) · Medical academic journal · doi:10.17816/maj16221-31
Cognitive Neurophysiology and in vivo Neurochemistry of Bipolar Disorder
Ilhan, A. M. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200527ma
de Oliveira, A. W. C. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Potenciales estrategias en el tratamiento de la depresión
Fernández, M. G. (2020) · UCrea (University of Cantabria)
Chen, R. (2020) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-bmqkevxok
Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine
Reischl, G. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-314-6
Психотропные и нейрорецепторные эффекты циклопролилглицина при интраназальном введении
Абдуллина, А. А., Васильева, Е. В., Кондрахин, Е. А., Колясникова, К. Н., Гудашева, Т. А., & Ковалёв, Г. И. (2021) · Химико-фармацевтический журнал · doi:10.30906/0023-1134-2021-55-5-25-31
Epilepsy in Alzheimer model mice with brain amyloidosis : possible mechanisms and treatment options
Ziyatdinova, S. (2017) · UEF eRepo (University of Eastern Finland)
PATHOPHYSIOLOGICAL ROLE OF ADENOSINERGIC MODULATION WITHIN THE BASOLATERAL COMPLEX OF THE AMYGDALA
Pliássova, A. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Psychotropic and Neuroreceptor Effects of Cyclopropylglycine Upon Intranasal Administration
Абдуллина, А. А., Васильева, Е. В., Кондрахин, Е. А., Колясникова, К. Н., Гудашева, Т. А., & Kovalev, G. I. (2021) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-021-02445-6
Morphometrische in-vivo-Untersuchungen des Hippocampus bei depressiven Patienten
Mühleder, R. K. (2014) · bonndoc (University of Bonn)
Thase, M. E. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.5960956.8788057
(2010) · Wiley eBooks · doi:10.1002/9780470689394.refs
Potential Novel Treatments in Bipolar Depression
Machado‐Vieira, R., Henter, I. D., Manji, H. K., & Zarate, C. A. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_12
Self-citation
Metadata
- Authors
- Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K.
- Affiliations
- Yale University (US)
- National Institutes of Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-05
- Volume
- 7
- Issue
- 5
- Pages
- 426-437
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC2715836
- OpenAlex
- W2074907255
- Cited by
- 894
- References
- 186
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 33 · 2023: 44 · 2022: 36 · 2021: 44 · 2020: 56 · 2019: 43 · 2018: 40 · 2017: 50 · 2016: 63 · 2015: 70 · 2014: 59 · 2013: 56 · 2012: 68
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (K02MH076222, Z01MH002828, Z01MH002857)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- glutamatergic system, mood disorders, antidepressants, neuroplasticity, glutamatergic agents, monoaminergic systems, rapid-acting antidepressants, drug development
- MeSH terms
- Animals, Glutamates, Humans, Psychotropic Drugs, Excitatory Amino Acid Antagonists, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.